Literature DB >> 15749897

Mechanisms of the natural reactivity of lymphocytes from noninfected individuals to membrane-associated Leishmania infantum antigens.

Atfa Sassi1, Beya Larguèche-Darwaz, Alexis Collette, Adrien Six, Dhafer Laouini, Pierre André Cazenave, Koussay Dellagi.   

Abstract

Membrane-associated Leishmania Ags (MLA) or soluble Leishmania Ags were used in vitro to stimulate cord blood or PBMC from healthy donors noninfected by Leishmania parasites. MLA, but not soluble Leishmania Ags, constantly induce strong proliferation of cord blood mononuclear cells and PBMC from noninfected individuals. Responding cells are CD3+, CD4+, TCRalphabeta+, CD45RO+, and CD45RA+ and secrete IFN-gamma and IL-10, but not IL-4. MLA do not activate NK cells nor NKT cells. Membrane Ags also induce purified macrophages from noninfected individuals to secrete IL-10 and TNF-alpha, but have no effect on IL-1alpha or IL-12 secretion. The effects of MLA are proteinase K-sensitive and resistant to lipid extraction. The lymphoproliferative responses are inhibited by anti-HLA-DR Abs and require Ag processing by APCs, excluding that the biological effect of MLA could be attributed to a superantigen. Finally, TCR repertoire analysis shows that the T cell expansion induced by MLA uses TCR with various variable beta segment rearrangements and CDR3 lengths, features much more characteristic to those observed with a polyclonal activator than with a conventional Ag. These results suggest a particular mechanism developed during the host's natural response to Leishmania parasites that allows direct activation of naive CD4 lymphocytes by parasite membrane-associated Ags.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749897     DOI: 10.4049/jimmunol.174.6.3598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination.

Authors:  Peter Crauwels; Rebecca Bohn; Meike Thomas; Stefan Gottwalt; Florian Jäckel; Susi Krämer; Elena Bank; Stefan Tenzer; Paul Walther; Max Bastian; Ger van Zandbergen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

2.  Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Authors:  Christodoulos Filippis; Katharina Arens; Gaetan Aime Noubissi Nzeteu; Gabriele Reichmann; Zoe Waibler; Peter Crauwels; Ger van Zandbergen
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

3.  Asymptomatic immune responders to Leishmania among HIV positive patients.

Authors:  Laura Botana; Ana Victoria Ibarra-Meneses; Carmen Sánchez; Alicia Castro; Juan Victor San Martin; Laura Molina; Jose Manuel Ruiz-Giardin; Eugenia Carrillo; Javier Moreno
Journal:  PLoS Negl Trop Dis       Date:  2019-06-03

4.  Test combination to detect latent Leishmania infection: A prevalence study in a newly endemic area for L. infantum, northeastern Italy.

Authors:  Alessandra Mistral De Pascali; Renato Todeschini; Simone Baiocchi; Margherita Ortalli; Luciano Attard; Ana Victoria Ibarra-Meneses; Eugenia Carrillo; Stefania Varani
Journal:  PLoS Negl Trop Dis       Date:  2022-08-15

5.  Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans.

Authors:  Jungang Xie; Larisa C Lotoski; Rishma Chooniedass; Ruey-Chyi Su; F Estelle R Simons; Joel Liem; Allan B Becker; Jude Uzonna; Kent T HayGlass
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

Review 6.  The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis.

Authors:  Adrien Six; Maria Encarnita Mariotti-Ferrandiz; Wahiba Chaara; Susana Magadan; Hang-Phuong Pham; Marie-Paule Lefranc; Thierry Mora; Véronique Thomas-Vaslin; Aleksandra M Walczak; Pierre Boudinot
Journal:  Front Immunol       Date:  2013-11-27       Impact factor: 7.561

7.  Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites.

Authors:  Helena Messlinger; Heidi Sebald; Lukas Heger; Diana Dudziak; Christian Bogdan; Ulrike Schleicher
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

8.  Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation.

Authors:  Yetemwork Aleka; Ana Victoria Ibarra-Meneses; Meseret Workineh; Fitsumbrhan Tajebe; Amare Kiflie; Mekibib Kassa Tessema; Roma Melkamu; Azeb Tadesse; Javier Moreno; Johan van Griensven; Eugenia Carrillo; Wim Adriaensen
Journal:  J Immunol Res       Date:  2020-01-23       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.